CVR number 34466661
Industry 86.2200 Specialist medical practice activities

GEOFFROY ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.7% 0.7% 0.7% 0.7% 0.7%  
Bankruptcy risk  6.3% 6.0% 5.3% 9.1% 5.0%  
Credit score (0-100)  39 39 41 26 43  
Credit rating  BBB BBB BBB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  582 661 594 537 574  
EBITDA  71.0 110 73.0 232 274  
EBIT  69.0 110 73.0 232 274  
Pre-tax profit (PTP)  68.0 109.0 70.0 232.0 277.8  
Net earnings  52.0 85.0 55.0 179.0 216.3  
Pre-tax profit without non-rec. items  68.0 109 70.0 232 278  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  138 169 167 288 446  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  306 320 268 413 580  
Net Debt  -284 -274 -225 -381 -553  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  582 661 594 537 574  
Gross profit growth  40.9% 13.6% -10.1% -9.6% 6.9%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  306 320 268 413 580  
Balance sheet change%  43.0% 4.6% -16.3% 54.1% 40.4%  
Added value  71.0 110.0 73.0 232.0 273.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -4 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  11.9% 16.6% 12.3% 43.2% 47.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  26.5% 35.5% 24.8% 68.1% 55.9%  
ROI %  49.6% 72.3% 43.5% 102.0% 75.7%  
ROE %  37.4% 55.4% 32.7% 78.7% 59.0%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  45.1% 52.8% 62.3% 69.7% 76.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -400.0% -249.1% -308.2% -164.2% -202.1%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.0 2.5 2.7 5.7 7.5  
Current Ratio  2.0 2.5 2.7 5.7 7.5  
Cash and cash equivalent  284.0 274.0 225.0 381.0 553.0  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  153.0 191.0 167.0 341.0 503.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  71 110 73 232 274  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  71 110 73 232 274  
EBIT / employee  69 110 73 232 274  
Net earnings / employee  52 85 55 179 216